MDT

100.71

0%↓

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

Home・Aandelen Lijst・Vivani Medical

Vivani Medical

Gesloten

1.35 -0.74

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.35

Max

1.4

Belangrijke statistieken
By Trading Economics
Werknemers	37

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+170.27% upside

Dividenden
By Dow Jones
Volgende Winsten	30 mrt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-21M 83M
Vorige openingsprijs	2.09
Vorige sluitingsprijs	1.35

Vivani Medical Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

26 jan 2026, 23:49 UTC

Populaire aandelen

Stocks to Watch: Agilysys, Nucor, Humana, UnitedHealth

26 jan 2026, 23:09 UTC

Belangrijke Marktbewegers

Health Insurers' Shares Fall After Government Proposes Flat Medicare Advantage Rate

26 jan 2026, 23:52 UTC

Marktinformatie

Gold's Path of Least Resistance Still Looks Higher, Technical Analysis Shows -- Market Talk

26 jan 2026, 23:46 UTC

Marktinformatie

Nikkei May Decline as Yen's Rebound Raises Caution Over Earnings -- Market Talk

26 jan 2026, 23:37 UTC

Marktinformatie

Gold Rises Amid Concerns Over Tariffs -- Market Talk

26 jan 2026, 22:41 UTC

Marktinformatie

Australian 4Q CPI To Provide Smoking Gun For Hike -- Market Talk

26 jan 2026, 22:26 UTC

Winsten

Karoon Expects Capex of US$110 Million-US$135 Million in 2026

26 jan 2026, 22:26 UTC

Winsten

Karoon Expects Operating Costs to Fall Once Transition of Bauna FPSO Operatorship Completes

26 jan 2026, 22:25 UTC

Winsten

Karoon Energy Expects Unit Production Cost of US$12-US$15/BOE in 2026

26 jan 2026, 22:25 UTC

Winsten

Karoon Energy Expects Output to Rise in 2H Following Bauna Investment Program

26 jan 2026, 22:25 UTC

Winsten

Karoon Energy Expects Output of 8.1 Million-9.2 Million BOE in 2026

26 jan 2026, 22:24 UTC

Winsten

Karoon Energy 4Q Sales Revenue US$156.1 Million

26 jan 2026, 22:23 UTC

Winsten

Karoon Energy 4Q Sales Volumes 2.65 Million BOE, Up 5% on Quarter

26 jan 2026, 22:23 UTC

Winsten

Karoon Energy: Bauna FPSO Efficiency Increased to 98.8%

26 jan 2026, 22:23 UTC

Winsten

Karoon Energy FY Oil, Natural Gas Production 10.3 Million BOE

26 jan 2026, 22:22 UTC

Winsten

Karoon Energy 4Q Oil, Natural Gas Production 2.37 Million BOE

26 jan 2026, 22:05 UTC

Acquisities, Fusies, Overnames

Fortescue: Alta Copper Shareholders Approve Takeover

26 jan 2026, 22:02 UTC

Acquisities, Fusies, Overnames

Senate Antitrust Panel Chair Raises Concerns Over Netflix-Warner Deal -- WSJ

26 jan 2026, 21:50 UTC

Marktinformatie

Winsten

Financial Services Roundup: Market Talk

26 jan 2026, 21:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

26 jan 2026, 21:34 UTC

Winsten

Nucor: Steel Products Segment Expected Improved Earnings in 1Q Due to Increased Volumes on Stable Pricing >NUE

26 jan 2026, 21:34 UTC

Winsten

Nucor: Steel Mills Segment Expected Increase Is Due to Higher Volumes and Higher Realized Prices Across All Major Pdt Categories >NUE

26 jan 2026, 21:34 UTC

Winsten

Nucor: Raw Materials Segment Is Expected to Have Increased Earnings in 1Q >NUE

26 jan 2026, 21:34 UTC

Winsten

Nucor: 1Q Earnings Expected to Increase Across All Three Operating Segments, With the Largest Increase in Steel Mills Segment >NUE

26 jan 2026, 21:30 UTC

Acquisities, Fusies, Overnames

Eaton Stock Rises on Spin-Off Plan. Why It's Going All-In on Planes and AI Data Centers. -- Barrons.com

26 jan 2026, 21:30 UTC

Winsten

Nucor 4Q Sales $7.69B >NUE

26 jan 2026, 21:30 UTC

Winsten

Nucor 4Q Net $378M >NUE

26 jan 2026, 21:30 UTC

Winsten

Nucor 4Q Steel Mills Total Shipments 5.91M Tons >NUE

26 jan 2026, 21:30 UTC

Winsten

Nucor 4Q Total Tons Shipped to Outside Customers Down 9% >NUE

26 jan 2026, 21:30 UTC

Winsten

Nucor 4Q EPS $1.64 >NUE

Peer Vergelijking

Prijswijziging

Vivani Medical Prognose

Koersdoel

By TipRanks

170.27% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 4 USD 170.27%

Hoogste 4 USD

Laagste 4 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Vivani Medical - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Vivani Medical - Dist in de afgelopen 3 maanden.

Financieel

Over Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.